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Canonical isoforms in different databases have been defined as the most prevalent, most
conserved, most expressed, longest, or the one with the clearest description of domains or post-
translational modifications. In this article, we revisit these definitions of canonical isoforms
based on functional genomics and proteomics evidence, focusing on mouse data. We report
a novel functional relationship network-based approach for identifying the highest connected
isoforms (HCIs). We show that 46% of these HCIs are not the longest transcripts. In addition,
this approach revealed many genes that have more than one highly connected isoforms. Av-
eraged across 175 RNA-seq datasets covering diverse tissues and conditions, 65% of the HCIs
show higher expression levels than nonhighest connected isoforms at the transcript level. At the
protein level, these HCIs highly overlap with the expressed splice variants, based on proteomic
data from eight different normal tissues. These results suggest that a more confident definition
of canonical isoforms can be made through integration of multiple lines of evidence, including
HCIs defined by biological processes and pathways, expression prevalence at the transcript
level, and relative or absolute abundance at the protein level. This integrative proteogenomics
approach can successfully identify principal isoforms that are responsible for the canonical
functions of genes.
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1 Introduction
In mammalian systems, more than 90% of the multiexon
genes are capable of producing multiple transcripts by al-
ternative splicing (AS) [1, 2], which may carry out similar,
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different, or even opposite biological functions [1–14]. The re-
sulting splice variants greatly increase the repertoire of gene
products and therefore their functional complexity. To inter-
rogate the main functions of these gene products, signifi-
cant efforts have been devoted to identifying the canonical,
major or principal isoform of each gene [15–18]. However,
the definition of canonical isoforms is complex and differ-
ent in different databases. For example, UniProt defines the
canonical isoforms as the most prevalent, most conserved,
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longest, or the one with clear description of domains or
posttranslational modifications (http://www.uniprot.org/
faq/30). UCSC designates the longest splice variant of a gene
as the canonical isoform (http://genome.ucsc.edu/cgi-bin/
hgTrackUi?db=hg19&g=knownGene). Rodriguez et al. de-
fined the principal or canonical isoforms as the most con-
served transcripts across related species and the ones that
specify functional units in their sequences [16]. Finally, the
“major” transcripts have been defined by their relatively high
expression level in multiple studies [17, 18], despite the com-
plex regulation of AS [10,19,20]most genes express onemajor
transcript based on genome-scale expression data in human
andmouse [15–18]. Bahar et al. observed that there is a single
dominant isoform per gene for 80% of genes based on full-
length transcript or expression sequence tag data [15]. The
ENCODE project [21] found that most genes express a ma-
jor transcript at a relatively high level, even when several AS
isoforms tend to be expressed simultaneously [17]. Similarly,
Gonza`lez-Porta et al. revealed one dominant transcript per
gene through transcriptome analysis of human tissues and
cell lines and hypothesized that, although some minor tran-
scriptsmay play a functional role in specific tissues, themajor
ones are likely to be the main contributors to the proteome
[18]. One interesting finding in these studies [15, 16, 18] is
that the expression-based or conservation-based principal iso-
forms share only a limited percentage of sequence (5075%)
with the longest isoforms, showing an inconsistency between
these definitions.
The above disparate definitions of canonical isoforms
(summarized in Supporting Information Table 1) call for an
approach that integrates multiple lines of evidence to refine
the identification of canonical isoforms, which more reliably
reflect the main functions of the genes. Recent developments
in proteogenomics approaches allow us to harness the wealth
of information available at the proteome level and apply it to
the available genomic and transcriptomic information [22].
Such a proteogenomics approach has been successfully used
in annotating expression sequence tag databases [23], predict-
ing novel genes [24–26], and correcting existing gene models
[24]. Most relevant to this study, a proteogenomics approach
can be used to correct or identify novel splice isoforms [22].
To address the challenge of identifying canonical isoforms,
we report here a proteogenomics approach that integrates
multiple levels of evidence, including functional relationship
networks based on genomic data, transcriptomic RNA-seq
data, and proteomic data. At the functional relationship net-
work level, the highest connected isoforms (HCIs) are iden-
tified based on cofunctional connections with many other
genes in the same biological pathways or processes. This
network was built by integrating heterogeneous functional
genomic data from RNA-seq, exon array, protein docking,
and pseudoamino acid composition [27]. We performed a
genome-scale analysis of the local isoform-level networks for
3427 validated multi-isoform mouse genes (based on Ref-
Seq database v37.2), and identified the HCIs for each multi-
isoform gene. At the transcript expression level, we found a
high level of overlap between the HCIs and relatively highly
expressed splice variants. At the protein level, we identified
the expressed isoforms to validate the canonical isoforms that
were identifiedbased on functional relationshipnetworks and
the transcriptomic data. We found significant overlap across
the canonical isoforms identified through these three levels
of analysis.
2 Materials and methods
2.1 The functional network approach for identifying
canonical isoforms
Functional approaches have been shown to be promising in
understanding for example gene functions, networks, and
gene–disease relationships [28–32]. In this work, functional
networks will be used to help identify canonical isoforms.
The rationale in identifying canonical isoforms that are rep-
resentative of their major gene functions is that they should
be supported by multiple levels of functional genomics
and proteomics evidence. The network-based approach
anticipates that these isoforms participate in important
biological pathways and processes, and therefore are ex-
pected to have more functional relationships with other
transcripts/proteins. To analyze such functional relation-
ships, we utilized the genome-wide functional relationship
network at the isoform level for the mouse, which was gen-
erated through Bayesian network based multiple instance
learning [27, 33–37]. This network integrates heterogeneous
genomic data at the isoform level, encompassing 11 RNA-
seq datasets (146 samples), 52 exon array datasets (1273
samples), 1 protein docking dataset, and 1 amino acid com-
position dataset. For each RNA-seq or exon array dataset, the
correlation between isoforms was calculated to be used as an
isoform pair feature; each score in the protein docking data
represents how likely two protein isoforms are to bind each
other; and the pseudoamino acid composition data reflect
how similar two proteins are in terms of both percent compo-
sition and physiochemical properties of amino acids [27]. The
algorithm is an iterativemethod, in which we used a Bayesian
classifier. Briefly, each isoform pair can be represented by an
n-dimensional feature vector (E1, E2, . . . , En). With the
Bayesian classifier, the probability that an isoform pair
belonging to the positive class can be calculated using the
following formula:




P(E i|y = 1)
C
(1)
where P(y = 1) is the prior probability for a sample (isoform
pair) to be positive, P(Ei|y = 1), i = 1, 2, . . . ,n, is the proba-
bility of the ith feature given the observed value, conditioned
that the isoformpair is functionally related andC is a constant
normalization factor. The functionally related isoform pairs
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are identified and used in the next iteration to train themodel
until convergence. In this network, each node represents an
isoform, and the connection between two isoforms (of differ-
ent genes) represents the probability ranging from 0 to 1 that
two isoforms work in the same biological process/pathway.
To quantify the likelihood that each isoform is function-
ally related to other isoforms through participating the same
biological process/pathway, we defined an average functional
relationship (AFR) score, which is calculated as the average
of the functional relationships between the isoform and its
top connected neighbors (Fig. 1A). The AFR score in this
work is calculated using a local network containing the top
25 functionally related neighbors, thereby avoiding weak and
noisy functional connections. The probabilistic AFR score
ranges from 0 to 1. Then, within each multi-isoform gene in
the mouse (3427 validated in the RefSeq database, version
37.2), we calculated an AFR score for each of its isoforms and
defined the one with the highest AFR score as the HCI of
this gene. The remaining isoforms are treated as nonhighest
connected isoforms (NCIs).
We expected that theAFR scores (representinghow “highly
connected” the isoforms are) would be quite different be-
tween HCI and corresponding NCIs for some genes, while
for other genes these values are similar. To quantify such
difference between isoforms of a multi-isoform gene, we cal-
culated the ratio of the maximal to minimal AFR score of
isoforms using the following formula:
r = AF Rmax/AF Rmin (2)
In the above equation, a higher ratio r represents more dif-
ference between the “highly functionally connected” isoform
and the relatively less functionally connected isoforms and
vice versa.
2.2 Processing heterogeneous RNA-seq data
A total of 117 mouse RNA-seq datasets (containing 811
experiments) from the Sequence Read Archive database were
initially downloaded on May 1, 2012. These data cover a wide
range of experimental conditions and different tissues. For
each experiment, TopHat (v2.0.051) [38,39] was used to align
the reads against the mouse reference genome (NCBI gene
build, version 37.2). The expression levels of transcripts in
terms of FPKM (fragments per kilobase of exon per million
fragments) were estimated using Cufflinks (v2.0.0) [38]. For
quality control, experiments with fewer than 10 million reads
or covering less than 50% of the genes were removed. We
finally obtained 41 datasets with 321 experiments with each
dataset containing at least four experiments. Within each
dataset, transcripts with missing values occurring in more
than 50% experiments were removed for ensuring accurate
expression value estimation. Of the 41, 11 RNA-seq datasets
were used to build the functional relationship network at the
splice isoform level for the mouse in our previous study [27].
The remaining 30 datasets were used as an independent
test set for analyzing the expression behaviors of HCIs and
NCIs in this study (Supporting Information File 1 for the
full description of the RNA-seq datasets used, Supporting
Information Fig. 1 for the number of expressed transcripts).
2.3 Proteomic data from eight normal tissues of
mouse
The proteins expressed in eight normal mouse tissues were
generated from publicly available data. Mass spectrometric
mzXML files for breast (PAe000416), liver (PAe000297), and
brain (PAe000359, PAe000370, PAe000373, and PAe000380)
were downloaded from PeptideAtlas [40]. The mzXML files
for the normal samples from these datasets were searched
against our custom built ECgene database using X!Tandem
software [41]; the search parameters used were the same
as those of the original studies. The custom ECgene
database was constructed by combining Ensembl and EC-
gene databases, as described previously [42]. Peptides iden-
tified with false discovery rate <1% were used to identify
the proteins. The splice variant protein identifications were
generated according to our published peptide to protein in-
tegration method [42]. The steps involved in the integration
algorithm are as follows:
(1) Peptides (false discovery rate <1%) are ordered by the
number of spectra matching each peptide.
(2) The peptide with the largest number of matching spectra
is selected.
(3) Proteins containing this peptide were ranked by decreas-
ing number of total distinct peptides identified, decreas-
ing number of total spectra, increasing expect value, and
then increasing protein length.
(4) The highest ranking protein was selected to be included
in thefinal integrated protein list; if a tie exists, preference
was given to an Ensembl protein over an ECgene protein.
(5) All other peptides contained within this protein were re-
moved from the peptide list.
(6) Steps 3–5 were repeated until no peptides remain in the
peptide list.
Only the splice variant proteins identified from the normal
tissue samples were used for this study.
Breast: Whiteaker et al. [43] performed LC-MS/MS of
tumor and normal mammary tissues from a conditional
HER2/neu-driven mouse model of breast cancer. The orig-
inal study reported that cancerous and normal tissues
were harvested from five doxycycline-inducible, MMTV-rtTA
/TetO-NeuNT mice and five normal mice, respectively, and
processed separately into tissue lysates. Two pools were
prepared, containing equal mass of protein, and digested
by trypsin for mass spectrometric analysis. This dataset
was utilized by Menon and Omenn [44] in our early
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Figure 1. Illustration of how to
identify HCI based on the func-
tional relationship network, us-
ing the Aanat gene as an ex-
ample. (A) In the functional
relationship network, a single
node represents an isoform and
the connection between two
isoforms represents the prob-
ability that they work in the
samebiological process or path-
way. The edge width repre-
sents the functional relationship
probability between two iso-
forms. The AFR score is cal-
culated as the average con-
nection of the top interactions
for each isoform. The AFR of
the two isoforms NM_009591.3
and NR_033223.1 of Aanat are
0.955 and 0.078, respectively.
Therefore, NM_009591.3 was
selected as the HCI of Aanat.
The ratio of the maximal AFR
score to the minimal AFR
score of each gene was cal-
culated. (B) Protein domain in-
formation based on Pfam for
NM_009591.3 and NR_033223.1.
NM_009551.3, the shorter tran-
script, has an active acetyltrans-
ferase domain, while the longer
transcript NR_033223.1 has no
domain identified.
studies of differential expression of splice isoforms in spe-
cific pathways in HER2/neu-driven breast cancers.
Liver: Shi et al. [45] reported a large-scale analysis of mouse
liver tissue comprising a novel fractionation approach and
high-accuracy MS techniques. Fractions enriched for soluble
and membrane proteins from frozen tissue were separated
by 1D electrophoresis followed by LC-MS/MS on the hybrid
linear ion trap Orbitrap mass spectrometer (Thermo Fisher
Scientific, Bremen, Germany).
Brain: The original study was conducted onmitochondrial,
microsomal, cytoplasmic, and nuclear brain fractions us-
ing LCQ Deca XP MS (PAe000359, PAe000370, PAe000373,
and PAe000380 at http://www.peptideatlas.org/repository/).
A single list of distinct splice variants expressed in the
brain was generated from the proteins identified from
the mass spectrometric data analyses of all four brain
fractions.
The splice variant proteins expressed in adrenal, colon, eye,
heart, and spleen were extracted from the protein list pro-
vided in the supplementary material of a published study
[46]. The original study used SILAC-labeled mice that were
grown for more than two generations on a diet containing
heavy lysine (Lys6–13C6) as their sole source of this amino
acid, leading to complete labeling of their proteome [46]. Pro-
tein extracts from all SILAC-labeled tissues were combined
to create a heavy spike-in protein standard; this standard was
mixed with each of the unlabeled tissues in equal amounts
[46]. LC-MS/MS measurements were performed on an Easy-
nano-LC coupled to a linear ion trap Orbitrap XL mass spec-
trometer. The SILAC labeled to unlabeled ratio values were
used for relative comparison of the protein expression across
the different tissues [46]. We extracted the proteins identified
for adrenal, colon, eye, heart, and spleen tissues when the la-
beled to unlabeled ratio wasmore than zero; these five tissues
were chosen among the 28 tissues investigated in the study,
as there were at least three genes withmore than one isoform
expressed. The numbers of identified protein isoforms in the
eight tissues were shown in Supporting Information Fig. 1.
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For this study, we considered only the proteins whose parent
genes are known to have multiple isoforms according to the
NCBI-validated isoform annotations.
3 Results
3.1 Identify the HCIs in the mouse based on
functional relationships
In the functional relationship network, a node represents
an isoform, and the edge between nodes represents the
probability (ranging from 0 to 1) that two isoforms work in
the same biological process or pathway based on integrating
heterogeneous experimental evidence. For each individual
isoform of a multi-isoform gene, all of its functional connec-
tions are sorted in decreasing order first. Then, we calculated
an AFR score as the average of the functional connection be-
tween the isoform and its top connected neighbors (Fig. 1A).
The reason that we chose only the top connected isoforms
is to avoid noisy connections and enable easy network
visualization. AFR is used to describe the likelihood that an
isoform would be functionally related to others. Taking the
arylalkylamine N-acetyltransferase gene Aanat as an exam-
ple, the AFR score of its isoform NM_009591.3 is 0.955. The
functional connections of this isoform are much stronger
than those of the other isoform NR_033223.1 (AFR = 0.078).
NM_009591.3 is therefore selected as the HCI of Aanat
(Fig. 1A). Consistent with the predictions, NM_009591.3 is
a protein-coding transcript containing a functional acetyl-
transferase domain (Fig. 1B), whereas NR_033223.1 is a
noncoding transcript containing a 5′-most translational start
codon, which renders it a candidate target for the nonsense-
mediated decay pathway based on the NCBI gene database,
directly supporting the prediction that NM_009591.3 cannot
be functionally highly connected to other proteins.
We identified the functionally HCIs for the 3427 multi-
isoform genes based on the RefSeq gene annotation of
mouse, resulting in 3427 HCIs and 5334 NCIs (Supporting
Information File 2). So far, the functions of the splice iso-
forms are mainly inferred through computational prediction
[35], instead of experimental validation. To our knowledge,
isoform-specific functions are known only for a limited num-
ber of genes, which can be found in a recent review [37].
Among the 3427 HCIs, 165 are noncoding RNAs, of which
most are from validated or predicted noncoding genes except
for six genes (Wac, Rai12, Zfp672, Ng23, 4930583H14RIK,
and Prr18), which is consistent with our expectation that
most coding gene functions are carried out by protein-coding
transcripts and noncoding gene functions by noncoding tran-
scripts.
There are cases in which the AFR scores of NCIs of genes
are very close to that of the HCI; such NCIs could also be
considered as highly connected isoforms. To cover such iso-
forms, we included them as HCI candidates if their AFR
scores were 80% or more than that of the HCI (Supporting
Figure 2. The distribution of the ratio of AFR scores between the
most “functional” isoform and the least “functional” one (calcu-
lated using Formula 2) of all the 3427 multi-isoform genes of the
mouse; 1829 of the 3427 genes have a ratio >1.5, implying the
diversity of functional relationship between isoforms of the same
gene. The ratio values range from 1.000 to 15.226.
Information File 3), which gives in total 2104HCI candidates.
When this threshold was set to 85 and 95%, the numbers of
HCI candidates were 1394 and 942, respectively. As an exam-
ple, the isoform NM_013472.4 (AFR = 0.484) of Anxa6 gene
is the HCI, and the isoform NM_001110211.1 (AFR = 0.426)
is its HCI candidate.
We further calculated the ratio of AFR values of the most
“functionally connected” isoform to the least “functionally
connected” one, using formula (2), for each multi-isoform
gene to see how different the functional relationship between
isoforms can be. The distribution of the fold change values is
shown in Fig. 2; 1829 of the 3427 genes (53.4%) have a value
>1.500, implying a high diversity of functional relationship
for many of the multi-isoform genes under study. The rest
of the genes (46.6%) have an r ratio less than 1.500, likely
implying that all isoforms of the gene carry out important
functions and caution should be taken to assign canonical
functional isoforms for these genes. For those genes having
three or more isoforms, we also calculated the ratio of its
highest AFR score to the second highest score to see how
close the AFR scores of top connected isoforms can be. The
distribution of this ratio (ranging from 1.000 to 9.656) is
shown in Supporting Information Fig. 2. Of the 1092 genes
coding at least three isoforms, we found that about 1/3 of
them show quite different AFR scores between their highest
and second-HCIs (ratio >1.500).
3.2 Comparison between the functionally HCIs, the
longest isoforms, and the most conserved
isoforms
Within the 3427 multi-isoform genes, we compared the
HCIs to the longest transcript or protein, if translated. We
found that 1833 HCIs (53.5%) are also the longest isoforms
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Table 1. The number of HCIs shared with canonical isoforms (defined as the longest transcripts) and the principal isoforms in the APPRIS
database (defined by sequence and conservation), respectively
Canonical isoforms APPRIS principal isoforms
Shared By chance Shareda) By chance
1833 (53.5%, p = 1.55 × 10−16) 1495 ± 23 (43.6% ± 0.6%) 1402 (75.7%, p = 1.32 × 10−30) 1074 ± 25 (58.0% ± 1.3%)
a) Of the 3427 multi-isoform genes, 1853 genes have annotated APPRIS principal isoforms.
(Table 1). Although the overlap is significant compared to the
number by chance (p = 1.55 × 10−16), there is often a large
discrepancy between the HCIs and the longest isoforms
(46.5% are inconsistent), indicating that the canonical
isoforms defined by sequence length alone may not correctly
reflect the ones with most functional connections (for full list
of comparison between functionally highly connected iso-
forms and the longest isoforms, see Supporting Information
File 4). The likely reason for this difference betweenHCIs and
the longest isoforms is that the HCIs are identified by func-
tional data whereas the longest isoforms are selected purely
by sequence. The HCI of Aanat is NM_009591.3 (1370 bp),
which is shorter than NR_033223.1 (1472 bp), providing an
example in which the HCI is not the longest (Fig. 1B).
We further compared the HCIs to the isoforms in the
APPRIS database [16], which are mainly based on sequence
conservation as well as protein structures. While 1853 of the
3427 multi-isoform genes have annotated APPRIS principal
isoforms, 1402 are in common (75.7%, p = 1.32 × 10−30;
Table 1, Supporting Information File 5). This fraction of over-
lapping is much higher than the overlap between the HCIs
and longest isoforms. This result is consistent with previous
observations at the gene level that the highest functionally
connected genes or geneswithmore interaction partners tend
to be more likely to be conserved in sequence [47], presum-
ably due to higher evolutionary pressure imposed on genes
with more interactions [48].
3.3 The HCIs show consistently higher expression
than other isoforms at the transcript level
We investigated the expression signature of the HCIs at
the transcript level. We compared the expression level
between HCIs and NCIs based on 175 RNA-seq samples
(from Sequence Read Archive, see dataset list in Supporting
Information File 1). At the threshold log2(FPKM) >−5, the
averaged number of expressed genes of these samples are
16 744. These 175 samples were not used in predicting the
isoform networks of the mouse [27] and therefore served as
independent evidence. They cover a variety of cell types and
tissues, including but not limited to embryonic stem cells,
muscle, kidney, liver, and brain. For each RNA-seq sample,
we calculated the average and distribution of expression
levels of the HCIs and NCIs, respectively. The mean of
expression values of HCIs and NCIs in each sample is shown
in Fig. 3A. Strikingly, we found that, regardless of different
tissues/cell lines and experimental conditions, on average
HCIs consistently show higher expression levels than NCIs
(see Supporting Information File 6) across all the samples
(Fig. 3), except for the ten samples of one RNA-seq dataset,
SRP008508. A 3′-end sequencing technique was used for
studying transcript expression in this atypical dataset, which
was not able to differentiate alternatively spliced isoforms.
We further computed the expression distributions of HCIs
and NCIs by combining all the experiments (Fig. 3B).
Although there is overlap between the expression levels
of HCIs and NCIs, we found that the expression levels of
HCIs are significantly higher than the NCIs (p < 1 × 10−20,
two-sample t-test). These results indicate a strong correlation
between the HCIs defined by pathways/biological processes
and the major transcripts defined as the relatively highly
expressed copy [17].
3.4 Refining canonical isoform identification using
proteomic datasets from diverse tissues
To investigate the expression patterns of HCIs at the protein
level, we collected eight sets of proteomic data covering liver,
breast, brain, adrenal, colon, eye, heart, and spleen in the
mouse. We identified highly confident isoforms expressed in
each tissue by their unique peptide sequences according to
the protocol described previously [41–43, 45, 46]. For multi-
isoform genes, we then compared the expressed isoform in
each tissue to the predicted HCIs. In total, we observed 323
genes, which have protein isoforms expressed. Of them, we
found that the HCIs of 206 genes overlap with the expressed
protein isoform in at least one tissue, which is significantly
higher (p< 10× 10−6) than the number by chance (166± 10)
cases. These results suggest the overall consistency between
HCIs identified by pathways and biological processes and the
major expressed isoforms at the proteomic level of different
tissues. For these 206 genes, the average expression at the
transcript level of HCIs is higher than that of NCIs (Fig. 3C),
which is expected based on the findings in Section 3.3. This
implies that HCI is a good indicator of expressed proteins at
both the transcript and protein level, although the correlation
between transcript and protein expression has been shown to
be usually from0.4 to 0.6 in previous studies [49,50]. For these
206 genes, the network-based, transcript expression based,
and proteomic data all identified the same isoform to be the
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Figure 3. Comparison of expression levels between HCIs and NCIs. (A) For each of the 175 RNA-seq samples we collected from SRA, the
mean expression was calculated for all HCIs and NCIs, respectively. Each dot represents the mean expression level of HCIs versus NCIs in
one RNA-seq sample. (B) The distributions of expression levels of HCIs and NCIs calculated by combining all the 175 RNA-seq samples. (C)
The expression values of HCIs against NCIs, averaged over the 175 RNA-seq samples, of which 206 genes have both transcript and protein
level expression. Each dot represents a HCI–NCI pair within a gene (in total 277 pairs).
canonical isoform, making them strong cases where multi-
ple lines of evidence support the identification of canonical
isoforms.
For the other 117 (323–206) genes, their HCIs do not over-
lap with the expressed protein isoforms. Further, for these
117 genes, the average expression of HCIs at the transcript
level is much higher than for NCIs (p < 5.9 × 10−20, Sup-
porting Information Fig. 3). There are at least three reasons
for this observation. First, for some genes, the AFR scores
of their isoforms (such as the HCI candidate discussed in
Section 3.1) are very close to that of HCI, indicating that
these isoforms may actually be equally functional. Thus, it
would be difficult to distinguish which isoform is the prin-
cipal one. For example, the AFR scores of the two isoforms
NM_009295.2 and NM_001113569.1 of the Stxbp1 gene are
0.980 and 0.973, respectively. The protein isoform identified
at the protein level was not the HCI (NM_009295.2) but the
other isoform (NM_001113569.1). Another example is the
Ptbp1 gene whose two isoforms have similar scores, but its
isoformwith the lower AFR score (NM_001077363.1) instead
of the HCI NM_008956.2, was also found in our proteomic
data (described in Section 2.3). Second, compared to tran-
scriptomic data, the number of proteins and protein isoforms
that can be confidently identified in a proteomic experiment is
smaller than for transcripts, with a lot of protein isoforms un-
detected. Third, we studied only eight tissues and the expres-
sion of certain isoforms can be tissue specific [51]. We listed
114 genes whose expressed proteins overlap with their HCIs
and meanwhile have a ratio >1.500 between the maximum
andminimumAFR values (see Formula 2). Table 2 presents a
list of isoformswith high confidence to be the canonical ones.
This list represents the canonical isoforms supported by both
participation in biological pathways and protein level expres-
sion.We observed that, for 35 of the 114 genes, theirHCIs are
expressed at the protein level in at least four tissues. For exam-
ple, the HCIs of Prosc (proline synthetase cotranscribed) and
Tardbp (TAR DNA binding protein) were observed in all the
eight tissues under study, which indicates that the biological
role of these two proteins is carried out in diverse tissues by
a single “functional” isoform. Other isoforms are only identi-
fied in some or one of the samples. These isoforms are either
tissue specific in expression or their expression was not iden-
tified due to the limited coverage of proteomic sequences. An
example of the former is Syn3 (Synapsin III), which encodes
a neuronal phosphoprotein and is brain specific (according
to its GeneCards expression profile): its HCI NM_013722.3
was found only in brain in our proteomic sample collection
(Table 2).
4 Discussion
AS results in isoforms that greatly increase the repertoire of
gene products and thus their functional complexity. To in-
terrogate the main functions of these gene products, many
studies have been devoted to identifying the canonical or
principal isoforms. Previous criteria on the selection of such
canonical isoforms are highly heterogeneous, based on se-
quence, conservation, expression, and existence of functional
domains [15–18, 52]. However, they rarely consider whether
the identified isoforms are indeed representative of themajor
function of the genes through analyzing their involvement in
pathways and with proteomic evidence.
In this work, we used multiple lines of evidence integrat-
ing both functional genomic data and proteomic data to refine
the identification of canonical isoforms. One important line
of evidence we used was based on a functional relationship
network, under the critical assumption that the function-
ally HCIs are more likely to represent the main functional
gene product. We found that a large proportion of the HCIs
are not the canonical isoforms as defined by the length of
the transcripts. However, they do show strong overlap with
themost conserved transcripts, the relatively highly expressed
copies at the RNA level, and the identified splice copies at the
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Table 2. The highest connected isoforms of 114 genes validated at the protein level using eight normal tissues of mousea)
Gene HCI Tissue Gene HCI Tissue
Aanat NM_009591.3 LV Snx7 NM_029655.3 AR, CL, SL
Cyp3a25 NM_019792.2 LV Sbsn NM_172205.3 AR, CL, EY, HT, SL
Mpp6 NM_019939.2 AR, CL, EY, HT, SL Wdr33 NM_028866.3 BN
Psmd2 NM_134101.2 LV, BN, AR, CL, EY, HT, SL Mrps33 NM_010270.2 LV, AR
Mrpl15 NM_001177658.1 LV Ahnak NM_009643.1 LV, BT, AR, CL, EY, HT, SL
Tsr2 NM_001164578.1 AR, CL, HT Lig1 NM_010715.2 AR, SL
Cstf3 NM_145529.3 LV Sorbs1 NM_001034964.1 BN
Adhfe1 NM_175236.4 LV Asb7 NM_080443.2 LV
Abca6 NM_147218.2 LV Pacsin3 NM_028733.3 AR, EY, HT
Ndufs6 NM_010888.2 LV Plin1 NM_175640.2 BT
Hspa13 NM_030201.3 LV Inadl NM_172696.2 LV, CL, SL
Pex16 NM_145122.2 LV Kctd14 NM_001012434.3 CL
Mrpl48 NM_198831.2 LV, AR, CL, EY, HT Cyp2c50 NM_134144.2 LV
Wdr13 NM_026137.4 AR Tmsb10 NM_025284.4 AR, CL, EY, SL
Prpsap2 NM_001164242.1 AR, CL, EY, HT, SL Pick1 NM_008837.2 AR, CL
Aspn NM_025711.3 AR, CL, EY, HT, SL Hagh NM_024284.2 AR, CL, EY, HT, SL
Adarb1 NM_130895.3 BN Copg2 NM_017478.2–2 LV
Prosc NM_054057.4 LV, BT, BN, AR, CL, EY, HT, SL Syt7 NM_173068.2 AR, CL
Wtap NM_001113533.1 CL Fam134c NM_026501.2 LV
Ociad1 NM_023429.4 LV Ikzf1 NM_001025597.1 SL
Dars NM_177445.5 LV, BN Inpp4a NM_030266.3 CL
Triobp NM_001024716.1 AR, CL, EY, HT, SL Setdb1 NM_001163641.1 SL
Dab1 NM_177259.3 LV Aspscr1 NM_026877.2 LV
Lrp4 NM_172668.3 LV Rab11fip1 NM_001080813.2 CL, SL
Gatad2a NM_145596.3 AR, CL Aamp NM_146110.3 CL
Ripk3 NM_019955.2 CL, SL Wdr61 NM_001025375.1 AR, CL, EY, HT, SL
Fbrsl1 NM_001142642.1 LV Wasl NM_028459.2 LV, AR, CL, EY, SL
Dlgap4 NM_001042487.1 AR, CL, EY, HT, SL Ncam1 NM_001081445.1 BN
Brdt NM_054054.2 LV Brd4 NM_198094.2 LV
Tsc22d1 NM_207652.2 AR, CL, EY, HT, SL Hnrnpa1 NM_001039129.3 AR, CL, EY, HT, SL
Nagk NM_019542.2 AR, CL, EY, HT, SL Egfr NM_207655.2 LV
Jak2 NM_008413.2 CL Ppih NM_028677.4 AR, CL, EY, HT, SL
Mkl2 NM_001122667.2 AR, CL, SL Dpp4 NM_010074.3 LV
Atp2a2 NM_001110140.3 LV Thnsl1 NM_177588.2 AR, CL, EY, HT
Abhd11 NM_145215.2 LV Tufm NM_172745.3 BT
Hgd NM_013547.3 LV Dnajc6 NM_001164583.1 LV
Pex5l NM_021483.3 AR, EY Pacsin2 NM_011862.3 AR, CL, EY, HT, SL
Nags NM_145829.1 LV Zfml NM_008717.3 BN, CL, SL
Syn3 NM_013722.3 BN Acbd6 NM_028250.3 LV
Ndrg2 NM_001145959.1 BN Bc030307 NM_001003910.2 LV
Copg NM_017477.2 LV Nfasc NM_182716.4 BN
Dazap1 NM_001122605.1 AR, CL, EY, SL Rrbp1 NM_024281.2 LV, BN
Golph3l NM_146133.3 AR, CL, EY, HT, SL Cd97 NM_011925.2 AR, CL, HT
Rlbp1 NM_020599.2 EY Epb4.1l1 NM_001003815.2 AR, CL, EY, SL
Grk4 NM_019497.2 LV Gngt2 NM_001038664.2 EY, SL
Brd2 NM_010238.3 AR, EY Pabpc4 NM_130881.2 AR, CL, EY, HT, SL
Slc25a21 NM_172577.3 LV Gimap4 NM_174990.3 AR, CL, EY, HT, SL
Bcap29 NM_001164090.1 AR Eif2ak4 NM_013719.3 CL, SL
Glrx2 NM_001038592.1 LV Pram1 NM_001002842.2 LV
Tardbp NM_145556.4 LV, BT, BN, AR, CL, EY, HT, SL Pacsin1 NM_011861.2 AR, CL, EY, HT, SL
Rps24 NM_207634.1 LV Erc1 NM_053204.2 LV, AR, CL, EY, HT, SL
Golga2 NM_133852.2 AR, CL, EY, HT, SL Lmna NM_001111102.1 AR, CL, EY, HT, SL
Tnpo2 NM_145390.4 AR, CL, EY, HT, SL Rdx NM_009041.3 AR, CL, EY, HT, SL
Acss3 NM_001142804.1 LV Ace2 NM_001130513.1 AR
Chchd6 NM_001167736.1 AR, CL, EY, HT Acp1 NM_021330.4 AR, CL, HT, SL
2310035c23rik NM_173187.3 AR, CL, EY, HT, SL Pnkd NM_025580.2 LV
Stk32c NM_021302.3 BN Eif4a2 NM_001123037.1 LV
a) Tissue abbreviation: LV, liver; BT, breast; BN, brain; AR, adrenal; CL, colon; EY, eye; HT, heart; SL, spleen. Only genes with the ratio of
maximum to minimum AFR scores >1.5 are listed here.
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protein level. Thesefindings support the prediction for canon-
ical isoforms by this integrative proteogenomic approach. On
the other hand, our current findingsmay be limited by factors
such as limited functional annotation data of splice isoforms,
protein expression data used in our study, and the small num-
ber of proteomic experiments. Also, expression of transcripts
and proteins are highly dynamic at different developmental
stages of tissues or cell lines, which might add further com-
plexity to the process of identifying canonical isoforms. It is
expected that more reliable results would be obtained if more
systematically processed proteomic data are available. Over-
all, the identified HCIs for the mouse provide an abundant
source for investigating main functional products of 3427
multi-isoform genes; 206 of them are also further confirmed
at the protein expression level. Our study adds a new aspect
to the current knowledge on principal isoforms mainly based
on sequence or conservation. We are building an analogous
functional relationship network with human datasets.
This work is supported by NIH grants 1R21NS082212-01
(YG) and RM08029 and U54ES017885 (GSO).
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